16 November 2009
GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction
10 November 2009
Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine
10 November 2009
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries
09 November 2009
Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)
09 November 2009
GlaxoSmithKline and XenoPort announce extension of GSK1838262 (XP13512) FDA review date to 9 February, 2010
06 November 2009
World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine
03 November 2009
World’s largest malaria vaccine trial now underway in seven African countries
03 November 2009
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care
02 November 2009
Retigabine Regulatory Update
02 November 2009
GlaxoSmithKline and Human Genome Sciences announce positive results in second of two phase 3 trials of Benlysta in systemic lupus erythematosus
Back to top

